Abstract
Keywords
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to British Journal of Oral and Maxillofacial SurgeryReferences
- Frequency of odontogenic cysts and tumors: a systematic review.J Investig Clin Dent. 2014; 5: 9-14https://doi.org/10.1111/jicd.12044
- Cyst or Tumor? A systematic review and meta-analysis on the expression of p53 marker in Odontogenic Keratocysts.J Cranio-Maxillo-Facial Surg Off Publ Eur Assoc Cranio-Maxillo-Facial Surg. 2021; 49: 1101-1106https://doi.org/10.1016/j.jcms.2021.09.015
- Keratocystic odontogenic tumour (KCOT)–a cyst to a tumour.Oral Maxillofac Surg. 2012; 16: 163-170https://doi.org/10.1007/s10006-011-0302-9
- Odontogenic Cysts.Dent Clin North Am. 2020; 64: 105-119https://doi.org/10.1016/j.cden.2019.08.002
- The odontogenic keratocyst: a cyst, or a cystic neoplasm?.J Dent Res. 2011; 90: 133-142https://doi.org/10.1177/0022034510379016
- Update from the 4th Edition of the World Health Organization Classification of Head and Neck Tumours: Odontogenic and Maxillofacial Bone Tumors.Head Neck Pathol. 2017; 11: 68-77https://doi.org/10.1007/s12105-017-0794-1
- Novel recurrence risk stratification of odontogenic keratocysts: A systematic review.Oral Dis. 2021; https://doi.org/10.1111/odi.13931
- Decompression or Marsupialization; Which Conservative Treatment is Associated with Low Recurrence Rate in Keratocystic Odontogenic Tumors? A Systematic Review.J Dent (Shiraz, Iran). 2019; 20: 145-151https://doi.org/10.30476/DENTJODS.2019.44899
- A systematic review of the recurrence rate for keratocystic odontogenic tumour in relation to treatment modalities.Int J Oral Maxillofac Surg. 2012; 41: 756-767https://doi.org/10.1016/j.ijom.2012.02.008
- Systematic review of the treatment and prognosis of the odontogenic keratocyst.Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2000; 90: 553-558https://doi.org/10.1067/moe.2000.110814
- Management and recurrence of keratocystic odontogenic tumor: a systematic review.Oral Surg Oral Med Oral Pathol Oral Radiol. 2013; 116: e271-e276https://doi.org/10.1016/j.oooo.2011.12.028
- Interventions for the treatment of keratocystic odontogenic tumours.Cochrane Database Syst Rev. 2015; 2015: CD008464https://doi.org/10.1002/14651858.CD008464.pub3
- What surgical treatment has the lowest recurrence rate following the management of keratocystic odontogenic tumor?: A large systematic review and meta-analysis.J Cranio-Maxillo-Facial Surg Off Publ Eur Assoc Cranio-Maxillo-Facial Surg. 2017; 45: 131-144https://doi.org/10.1016/j.jcms.2016.10.013
- How well do we manage the odontogenic keratocyst? A multicenter study.Oral Surg Oral Med Oral Pathol Oral Radiol. 2019; 127: 282-288https://doi.org/10.1016/j.oooo.2018.12.001
- Conservative surgical treatments for nonsyndromic odontogenic keratocysts: a systematic review and meta-analysis.Clin Oral Investig. 2018; 22: 2089-2101https://doi.org/10.1007/s00784-017-2315-8
- Recurrence Rates of Odontogenic Keratocysts Treated with Carnoy’s Compared to Modified Carnoy’s Solution.J Oral Maxillofac Surg. 2020; 78: e29-e30https://doi.org/10.1016/J.JOMS.2020.07.077
- Topical 5-Fluorouracil is a Novel Targeted Therapy for the Keratocystic Odontogenic Tumor.J Oral Maxillofac Surg. 2017; 75: 514-524https://doi.org/10.1016/j.joms.2016.09.039
- 5-Fluorouracil: mechanisms of action and clinical strategies.Nat Rev Cancer. 2003; 3: 330-338https://doi.org/10.1038/nrc1074
RoB 2: A revised Cochrane risk-of-bias tool for randomized trials | Cochrane Bias. Available at https://methods.cochrane.org/bias/resources/rob-2-revised-cochrane-risk-bias-tool-randomized-trials [Accessed February 3, 2022].
Risk of bias tools – robvis (visualization tool). Available at https://www.riskofbias.info/welcome/robvis-visualization-tool [Accessed February 3, 2022].
GRADEpro. Available at https://www.gradepro.org/ [Accessed February 3, 2022].
- Topical 5-fluorouracil application in management of odontogenic keratocysts.J Oral Biol Craniofacial Res. 2020; 10: 404-406https://doi.org/10.1016/j.jobcr.2020.07.008
- 5-Fluorouracil Is Associated With a Decreased Recurrence Risk in Odontogenic Keratocyst Management: A Retrospective Cohort Study.J Oral Maxillofac Surg. 2021; 79: 814-821https://doi.org/10.1016/j.joms.2020.07.215
- Critical time of exposure of the rabbit inferior alveolar nerve to Carnoy’s solution.J Oral Maxillofac Surg. 1994; 52: 599-606https://doi.org/10.1016/0278-2391(94)90098-1
- A systematic review of the pathophysiology of 5-fluorouracil-induced cardiotoxicity.BMC Pharmacol Toxicol. 2014; 15: 47https://doi.org/10.1186/2050-6511-15-47
- Intralesional 5-fluorouracil in keloid treatment: a systematic review.Acta Derm Venereol. 2015; 95: 778-782https://doi.org/10.2340/00015555-2106
- Intralesional and Laser-Assisted 5-Fluorouracil in Dermatologic Disease: A Systematic Review.J Drugs Dermatol. 2018; 17: 274-280
- Cryosurgery and topical fluorouracil: a treatment method for widespread basal cell epithelioma in basal cell nevus syndrome.J Dermatol. 1993; 20: 507-513https://doi.org/10.1111/j.1346-8138.1993.tb01330.x
- 5-Fluorouracil Management of Oculofacial Scars: A Systematic Literature Review.Ophthalmic Plast Reconstr Surg. 2020; 36: 222-230https://doi.org/10.1097/IOP.0000000000001532
- Postoperative 5-Fluorouracil for glaucoma surgery.in: Wormald R. Cochrane Database of Systematic Reviews. John Wiley & Sons, Ltd, Chichester, UK, England2001: CD001132
Fluorouracil topical Use During Pregnancy | Drugs.com. Available at https://www.drugs.com/pregnancy/fluorouracil-topical.html [Accessed February 3, 2022].
- 5-Fluorouracil and dihydropyrimidine dehydrogenase.Int J Clin Oncol. 2003; 8: 127-131https://doi.org/10.1007/S10147-003-0319-7
- Topical Imiquimod or Fluorouracil Therapy for Basal and Squamous Cell Carcinoma.Arch Dermatol. 2009; 145: 1431-1438https://doi.org/10.1001/archdermatol.2009.291